198 related articles for article (PubMed ID: 24045109)
1. Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients.
Mese S; Arikan M; Cakiris A; Abaci N; Gumus E; Kursun O; Onel D; Ustek D; Kaymakoglu S; Badur S; Yenen OS; Bozkaya E
J Gen Virol; 2013 Dec; 94(Pt 12):2729-2738. PubMed ID: 24045109
[TBL] [Abstract][Full Text] [Related]
2. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).
Osiowy C; Villeneuve JP; Heathcote EJ; Giles E; Borlang J
J Clin Microbiol; 2006 Jun; 44(6):1994-7. PubMed ID: 16757589
[TBL] [Abstract][Full Text] [Related]
3. HBV/4DR 9G test and its comparison with INNO-LiPA HBV multi-DR test for the detection of drug-resistant Hepatitis B virus.
Chantratita W; Song KS; Pongthanapisith V; Thongbaiphet N; Angkanavin K; Nimse SB; Sonawane MD; Kim T
J Virol Methods; 2016 Nov; 237():58-63. PubMed ID: 27581951
[TBL] [Abstract][Full Text] [Related]
4. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay.
Lok AS; Zoulim F; Locarnini S; Mangia A; Niro G; Decraemer H; Maertens G; Hulstaert F; De Vreese K; Sablon E
J Clin Microbiol; 2002 Oct; 40(10):3729-34. PubMed ID: 12354872
[TBL] [Abstract][Full Text] [Related]
5. [YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].
Arslan U; Ural O; Findik D
Mikrobiyol Bul; 2008 Jul; 42(3):445-50. PubMed ID: 18822888
[TBL] [Abstract][Full Text] [Related]
6. [Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year].
Aydoğan S; Ergünay K; Balaban Y; Alp A; Simşek H; Tatar G; Hasçelik G; Us D
Mikrobiyol Bul; 2013 Jul; 47(3):472-81. PubMed ID: 23971924
[TBL] [Abstract][Full Text] [Related]
7. Comparison of INNO-LIPA and TRUGENE assays for genotyping and drug-resistance mutations in chronic hepatitis B virus infection.
Basaras M; Arrese E; Blanco S; Arroyo LS; Ruiz P; Cisterna R
Intervirology; 2013; 56(3):190-4. PubMed ID: 23594698
[TBL] [Abstract][Full Text] [Related]
8. Validation of the INNO-LiPA HBV DR assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment.
Niesters HG; Zoulim F; Pichoud C; Buti M; Shapiro F; D'Heuvaert N; Celis L; Doutreloigne J; Sablon E
Antimicrob Agents Chemother; 2010 Mar; 54(3):1283-9. PubMed ID: 20065049
[TBL] [Abstract][Full Text] [Related]
9. Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay.
Libbrecht E; Doutreloigne J; Van De Velde H; Yuen MF; Lai CL; Shapiro F; Sablon E
J Clin Microbiol; 2007 Dec; 45(12):3935-41. PubMed ID: 17913933
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions.
Aberle SW; Kletzmayr J; Watschinger B; Schmied B; Vetter N; Puchhammer-Stöckl E
J Clin Microbiol; 2001 May; 39(5):1972-4. PubMed ID: 11326026
[TBL] [Abstract][Full Text] [Related]
11. Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir.
Hussain M; Fung S; Libbrecht E; Sablon E; Cursaro C; Andreone P; Lok AS
J Clin Microbiol; 2006 Mar; 44(3):1094-7. PubMed ID: 16517902
[TBL] [Abstract][Full Text] [Related]
12. Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations.
Olivero A; Ciancio A; Abate ML; Gaia S; Smedile A; Rizzetto M
J Viral Hepat; 2006 Jun; 13(6):355-62. PubMed ID: 16842437
[TBL] [Abstract][Full Text] [Related]
13. Lamivudine and Adefovir Motif Variants Detected in chronic Hepatıtıs B patients.
Ozekinci T; Mese S; Ozbek E; Atmaca S
Clin Ter; 2014; 165(1):13-7. PubMed ID: 24589944
[TBL] [Abstract][Full Text] [Related]
14. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
[TBL] [Abstract][Full Text] [Related]
15. Prevelance of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population.
Alagozlu H; Ozdemir O; Koksal B; Yilmaz A; Coskun M
Asian Pac J Cancer Prev; 2013; 14(9):5489-94. PubMed ID: 24175847
[TBL] [Abstract][Full Text] [Related]
16. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
[TBL] [Abstract][Full Text] [Related]
17. Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico.
Alvarado-Esquivel C; de la Ascensión Carrera-Gracia M; Conde-González CJ; Juárez-Figueroa L; Ruiz-Maya L; Aguilar-Benavides S; Torres-Valenzuela A; Sablon E
J Antimicrob Chemother; 2006 Feb; 57(2):221-3. PubMed ID: 16373428
[TBL] [Abstract][Full Text] [Related]
18. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H
Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924
[TBL] [Abstract][Full Text] [Related]
19. Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.
Mirandola S; Campagnolo D; Bortoletto G; Franceschini L; Marcolongo M; Alberti A
J Viral Hepat; 2011 Jul; 18(7):e212-6. PubMed ID: 21692935
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sequence analysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis B.
Sertoz RY; Erensoy S; Pas S; Akarca US; Ozgenc F; Yamazhan T; Ozacar T; Niesters HG
J Chemother; 2005 Oct; 17(5):514-20. PubMed ID: 16323440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
